Home
Live Updates
ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant to Advance GPR35 Inhibitor Program for Treatment of Gastrointestinal Disease and Cancers : comparemela.com
ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant to Advance GPR35 Inhibitor Program for Treatment of Gastrointestinal Disease and Cancers
/PRNewswire/ -- ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for...
Related Keywords
United Kingdom ,
James Westcott ,
United Kingdom Research ,
Innovation Centre On Milton Park ,
Prestigious Award Provides Non Dilutive Funding ,
Support Preclinical Activities Designed ,
Enable Translational Studies ,
Clinical Development ,
Thirtyfivebio Limited ,
Biomedical Catalyst ,
Innovate United Kingdom ,
Fivebio Limited ,
Canaan Partners ,
Innovation Centre ,
Milton Park ,
Strategic Partners ,
Thirtyfivebio ,
comparemela.com © 2020. All Rights Reserved.